These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5259761)

  • 21. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.
    James JA; Kaufman KM; Farris AD; Taylor-Albert E; Lehman TJ; Harley JB
    J Clin Invest; 1997 Dec; 100(12):3019-26. PubMed ID: 9399948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation of human leukocytes with Epstein-Barr virus after cellular exposure to chemical or physical mutagens.
    Henderson EE; Ribecky R
    J Natl Cancer Inst; 1980 Jan; 64(1):33-9. PubMed ID: 6243375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus.
    Gallagher RE; Salahuddin SZ; Hall WT; McCredie KB; Gallo RC
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4137-41. PubMed ID: 172897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome patterns of human leukocyte established cell lines.
    Miles CP; O'Neill F; Armstrong D; Clarkson B; Keane J
    Cancer Res; 1968 Mar; 28(3):481-90. PubMed ID: 5640868
    [No Abstract]   [Full Text] [Related]  

  • 26. Viruses in human tumors. I. Hodgkin's disease.
    Stewart SE; Mitchell EZ; Whang JJ; Dunlop WR; Ben T; Nomura S
    J Natl Cancer Inst; 1969 Jul; 43(1):1-14. PubMed ID: 5804605
    [No Abstract]   [Full Text] [Related]  

  • 27. Postmortem leukocyte culture studies in sudden infant death.
    Weinberg SB; Purdy BA
    Nature; 1970 Jun; 226(5252):1264-5. PubMed ID: 5463603
    [No Abstract]   [Full Text] [Related]  

  • 28. Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Robinson JE; Andiman WA; Henderson E; Miller G
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):749-53. PubMed ID: 191824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Micromethod for obtaining leukocyte cultures from peripheral blood].
    Stopchanskaia AG; Trubina LM
    Lab Delo; 1970; 8():463-6. PubMed ID: 4099998
    [No Abstract]   [Full Text] [Related]  

  • 30. Epstein-Barr virus: comparison of different strains for their biological activities in vitro.
    Furukawa T
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):543-53. PubMed ID: 166422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation.
    Yenamandra SP; Klein G; Kashuba E
    Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE; Alfieri C
    Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Miller G; Robinson J; Heston L; Lipman M
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4006-10. PubMed ID: 4372601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).
    Gerber P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):83-5. PubMed ID: 4550512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.
    Rocchi G; Felici A; Ragona G; Heinz A
    N Engl J Med; 1977 Jan; 296(3):132-4. PubMed ID: 187934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation of Epstein-Barr virus immortalized human B-cells by chemical carcinogens.
    Kessler DJ; Heilman CA; Cossman J; Maguire RT; Thorgeirsson SS
    Cancer Res; 1987 Jan; 47(2):527-31. PubMed ID: 3491677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
    Felton SC; Hoffmann CC; Kreier JP; Glaser R
    Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus infection and neoplasia.
    Sprinkle PM; Veltri RW
    Otolaryngol Head Neck Surg; 1981; 89(4):542-4. PubMed ID: 6270614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpesviruses and cancer in man and subhuman primates.
    Ablashi DV; Easton JM; Guegan JH
    Biomedicine; 1976 Nov; 24(5):286-305. PubMed ID: 187259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.